Similar articles

• Synergistic effect of testosterone and of a luteinizing hormone-releasing hormone agonist on androgen receptor content in the ventral prostate of castrated rats.

  Fiorelli G, Zoppi S, Kohen F, Motta M. Fiorelli G, et al. Steroids. 1989 Jan-Feb;53(1-2):195-217. doi: 10.1016/0039-128x(89)90153-0. Steroids. 1989. PMID: 2505407
• Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.

  Rowley DR, Thompson SA, Lubaroff DM, Heidger PM Jr. Rowley DR, et al. Prostate. 1984;5(1):101-11. doi: 10.1002/pros.2990050110. Prostate. 1984. PMID: 6607463
• Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues.

  Raynaud JP, Bonne C, Bouton MM, Lagace L, Labrie F. Raynaud JP, et al. J Steroid Biochem. 1979 Jul;11(1A):93-9. doi: 10.1016/0022-4731(79)90281-4. J Steroid Biochem. 1979. PMID: 385986 No abstract available.
• Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.

  Brinkmann AO, Lindh LM, Breedveld DI, Mulder E, Van Der Molen HJ. Brinkmann AO, et al. Mol Cell Endocrinol. 1983 Oct;32(2-3):117-29. doi: 10.1016/0303-7207(83)90076-x. Mol Cell Endocrinol. 1983. PMID: 6227511
• Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881).

  van Roijen JH, Ooms MP, Weber RF, Brinkmann AO, Grootegoed JA, Vreeburg JT. van Roijen JH, et al. J Androl. 1997 Jan-Feb;18(1):51-61. J Androl. 1997. PMID: 9089068